The Recall Desk
ModerateFDA (Drugs)·D-0393-2025·Announced 2025-05-07

Wegovy injection recalled due to temperature exposure during shipping

Cardinal Health is recalling Wegovy (semaglutide) 2.4 mg injection due to temperature abuse during shipping. Product was removed from refrigerated storage for an extended period due to a distribution center error.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This is an FDA Class II recall involving potential loss of product efficacy due to temperature excursion. The source text does not report any illnesses, injuries, or confirmed harm, and the hazard is storage-condition noncompliance rather than contamination or structural defect.

Plain-English summary

Cardinal Health Inc. is recalling Wegovy (semaglutide) 2.4 mg/0.75 mL injection in single-dose prefilled pens. The recall affects 48 cartons with lot number PZFDE06 (expiration 08/31/2025) distributed to North Carolina, South Carolina, and Virginia.

The product was potentially exposed to temperatures outside its labeled storage requirements due to a shipping error at a Cardinal Health distribution center. Specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.

Consumers who have received affected product should contact their healthcare provider or pharmacist. The FDA classifies this recall as Class II.

The recalled product

Product
WEGOVY (SEMAGLUTIDE)
Brand
WEGOVY
Manufacturer
Cardinal Health Inc.
Category
Drug — Injectable / Prescription
Hazard
  • temperature-abuse
  • storage-condition-noncompliance

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot PZFDE06
  • Exp 08/31/2025

Distribution

Distributed in 3 states:

  • NC
  • SC
  • VA

Related recalls

Same category